Amedisys Inc. Stock
Amedisys Inc. Stock
Amedisys Inc. is currently one of the favorites of our community with 14 Buy predictions and no Sell predictions.
As a result the target price of 92 € shows a slightly positive potential of 8.88% compared to the current price of 84.5 € for Amedisys Inc..
Pros and Cons of Amedisys Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amedisys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amedisys Inc. | - | 0.595% | 0.595% | 19.014% | 0.000% | -60.142% | -17.513% |
| Amn Healthcare Svs | - | 0.909% | 0.909% | -34.320% | -17.164% | -22.917% | 22.220% |
| Chemed Corp. | -0.930% | - | - | - | - | - | - |
| Select Medical Holdings | 1.320% | - | - | - | - | - | - |
Comments
Amedisys, Inc. (NASDAQ: AMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat